SU638260A3 - Способ получени 6-хлор-2-(1"пиперазинил) пиразина - Google Patents
Способ получени 6-хлор-2-(1"пиперазинил) пиразинаInfo
- Publication number
- SU638260A3 SU638260A3 SU762346054A SU2346054A SU638260A3 SU 638260 A3 SU638260 A3 SU 638260A3 SU 762346054 A SU762346054 A SU 762346054A SU 2346054 A SU2346054 A SU 2346054A SU 638260 A3 SU638260 A3 SU 638260A3
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- chlor
- pyrazine
- piperazinyl
- obtaining
- temperature
- Prior art date
Links
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 title 2
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 title 1
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/20—Nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Child & Adolescent Psychology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US57005275A | 1975-04-21 | 1975-04-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SU638260A3 true SU638260A3 (ru) | 1978-12-15 |
Family
ID=24277994
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU762346054A SU638260A3 (ru) | 1975-04-21 | 1976-04-20 | Способ получени 6-хлор-2-(1"пиперазинил) пиразина |
Country Status (36)
| Country | Link |
|---|---|
| JP (1) | JPS51136688A (es) |
| AR (1) | AR210349A1 (es) |
| AT (1) | AT353795B (es) |
| AU (1) | AU496854B2 (es) |
| BE (1) | BE840904A (es) |
| BG (1) | BG34185A3 (es) |
| CA (1) | CA1059128A (es) |
| CH (1) | CH619462A5 (es) |
| CS (1) | CS195726B2 (es) |
| CY (1) | CY1090A (es) |
| DD (1) | DD124599A5 (es) |
| DE (1) | DE2617205C3 (es) |
| DK (1) | DK143899C (es) |
| EG (1) | EG12387A (es) |
| ES (4) | ES447150A1 (es) |
| FI (1) | FI62666C (es) |
| FR (1) | FR2308367A1 (es) |
| GB (1) | GB1492528A (es) |
| GR (1) | GR59900B (es) |
| HK (1) | HK60380A (es) |
| HU (1) | HU172684B (es) |
| IE (1) | IE42979B1 (es) |
| IL (1) | IL49391A (es) |
| KE (1) | KE3088A (es) |
| LU (1) | LU74795A1 (es) |
| MY (1) | MY8100225A (es) |
| NL (1) | NL167692C (es) |
| NO (1) | NO146599C (es) |
| PH (1) | PH12274A (es) |
| PL (1) | PL99664B1 (es) |
| PT (1) | PT65027B (es) |
| RO (1) | RO73278A (es) |
| SE (1) | SE421695B (es) |
| SU (1) | SU638260A3 (es) |
| YU (1) | YU100676A (es) |
| ZA (1) | ZA762320B (es) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4091098A (en) * | 1977-04-25 | 1978-05-23 | Merck & Co., Inc. | 3-(1-PIPERAZINYL)-1,2,4-BENZOTRIAZINES AND N-oxides |
| US4163849A (en) | 1978-03-17 | 1979-08-07 | Merck & Co., Inc. | Piperazinylpyrazines |
| US4252816A (en) * | 1979-12-03 | 1981-02-24 | Merck & Co., Inc. | Tetrahydro-1H-1,4-diazepino(1,7-a)benzimidazoles useful as analgesic agents |
| US4339579A (en) | 1980-12-29 | 1982-07-13 | American Home Products Corporation | 2,6-Bis-(pyrrolopyrazinyl)pyrazines |
| EP0094498A3 (en) * | 1982-05-06 | 1985-04-03 | American Cyanamid Company | Antiatherosclerotic 1-piperazine derivatives |
| US4547505A (en) * | 1983-03-25 | 1985-10-15 | Degussa Aktiengesellschaft | N-Phenyl-N-'-cycloalkylalkanoylpiperazine useful as analgetics and process for its production |
| US4788290A (en) * | 1987-12-11 | 1988-11-29 | American Home Products Corporation | Serotonergic pyrazine derivatives |
| EP0580465A1 (fr) * | 1992-06-25 | 1994-01-26 | Sanofi | Nouvelle utilisation thérapeutique d'hétérocyclyl-pipérazines comme 5-HT3 agonistes et nouveaux dérivés |
| EE04588B1 (et) | 1997-10-27 | 2006-02-15 | Neurosearch A/S | Heteroarüüldiasatsükloalkaanid kui atsetüülkoliini nikotiinretseptorite kolinergilised ligandid, nende kasutamine ravimitena ning neid sisaldav farmatseutiline kompositsioon |
| ATE245153T1 (de) * | 1999-04-26 | 2003-08-15 | Neurosearch As | Heteroaryl-diazacycloalkane, ihre herstellung und verwendung |
| AU783915B2 (en) * | 2000-02-16 | 2005-12-22 | Neurogen Corporation | Substituted arylpyrazines |
| US6825198B2 (en) * | 2001-06-21 | 2004-11-30 | Pfizer Inc | 5-HT receptor ligands and uses thereof |
| WO2004009586A1 (en) | 2002-07-19 | 2004-01-29 | Biovitrum Ab | Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders |
| SE0202287D0 (sv) * | 2002-07-19 | 2002-07-19 | Biovitrum Ab | New compounds |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2606906A (en) * | 1948-10-14 | 1952-08-12 | American Cyanamid Co | 1-(2-pyridyl) piperazine and process of preparing same |
-
1976
- 1976-04-07 SE SE7604093A patent/SE421695B/xx not_active IP Right Cessation
- 1976-04-07 EG EG76205A patent/EG12387A/xx active
- 1976-04-07 DK DK164476A patent/DK143899C/da not_active IP Right Cessation
- 1976-04-08 NO NO761207A patent/NO146599C/no unknown
- 1976-04-09 NL NL7603800A patent/NL167692C/xx not_active IP Right Cessation
- 1976-04-09 FI FI760978A patent/FI62666C/fi not_active IP Right Cessation
- 1976-04-12 IL IL49391A patent/IL49391A/xx unknown
- 1976-04-13 AU AU12966/76A patent/AU496854B2/en not_active Expired
- 1976-04-13 GR GR50538A patent/GR59900B/el unknown
- 1976-04-13 PH PH18329A patent/PH12274A/en unknown
- 1976-04-14 CA CA250,732A patent/CA1059128A/en not_active Expired
- 1976-04-14 FR FR7610958A patent/FR2308367A1/fr active Granted
- 1976-04-15 CY CY1090A patent/CY1090A/xx unknown
- 1976-04-15 GB GB15644/76A patent/GB1492528A/en not_active Expired
- 1976-04-15 DD DD192399A patent/DD124599A5/xx unknown
- 1976-04-16 CS CS762549A patent/CS195726B2/cs unknown
- 1976-04-19 ES ES447150A patent/ES447150A1/es not_active Expired
- 1976-04-19 JP JP51043763A patent/JPS51136688A/ja active Granted
- 1976-04-20 CH CH492676A patent/CH619462A5/de not_active IP Right Cessation
- 1976-04-20 ZA ZA762320A patent/ZA762320B/xx unknown
- 1976-04-20 AT AT288376A patent/AT353795B/de not_active IP Right Cessation
- 1976-04-20 BG BG032968A patent/BG34185A3/xx unknown
- 1976-04-20 PL PL1976188912A patent/PL99664B1/pl unknown
- 1976-04-20 SU SU762346054A patent/SU638260A3/ru active
- 1976-04-20 RO RO7685688A patent/RO73278A/ro unknown
- 1976-04-20 BE BE166282A patent/BE840904A/xx not_active IP Right Cessation
- 1976-04-20 LU LU74795A patent/LU74795A1/xx unknown
- 1976-04-20 DE DE2617205A patent/DE2617205C3/de not_active Expired
- 1976-04-20 AR AR262930A patent/AR210349A1/es active
- 1976-04-20 YU YU01006/76A patent/YU100676A/xx unknown
- 1976-04-21 PT PT65027A patent/PT65027B/pt unknown
- 1976-04-21 HU HU76ME00001967A patent/HU172684B/hu unknown
- 1976-04-21 IE IE828/76A patent/IE42979B1/en unknown
-
1977
- 1977-06-01 ES ES459407A patent/ES459407A1/es not_active Expired
- 1977-06-01 ES ES459406A patent/ES459406A1/es not_active Expired
- 1977-06-01 ES ES459405A patent/ES459405A1/es not_active Expired
-
1980
- 1980-10-02 KE KE3088A patent/KE3088A/xx unknown
- 1980-10-30 HK HK603/80A patent/HK60380A/xx unknown
-
1981
- 1981-12-30 MY MY225/81A patent/MY8100225A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SU645559A3 (ru) | Способ получени производных оксима или их солей | |
| SU638260A3 (ru) | Способ получени 6-хлор-2-(1"пиперазинил) пиразина | |
| SE434049B (sv) | Forfarande for framstellning av 1,4-dihydropyridinderivat | |
| FI781955A7 (fi) | Foerfarande foer framstaellning av farmakologiskt anvaendbara 1,2,3,6-tetrahydroisonikotinsyraderivater | |
| IT1054791B (it) | Circuito amplificatore differenziale | |
| SE431456B (sv) | Analogiforfarande for framstellning av kondenserade kinazolonderivat | |
| SE443981B (sv) | Analogiforfarande for framstellning av syn-isomerer av 3,7 disubstituerade 3-cefem-4-karboxylsyraforeningar | |
| NL7612201A (nl) | Retinezuurderivaten. | |
| NL7613659A (nl) | Hydroxybenzylmalonzuurderivaten. | |
| NL7601122A (nl) | Cyclohexaanderivaten. | |
| DK153150C (da) | Analogifremgangsmaade til fremstilling af 4-oxo-1,6,7,8-tetrahydro-4h-pyridooe1,2aaapyrimidinderivater | |
| NL7609137A (nl) | Fenoxyalkylcarbonzuurderivaten. | |
| BG30778A3 (en) | Method for obtaining of eburnamenine derivatives | |
| NL7714372A (nl) | Fosfoncarbonzuurderivaten, alsmede werkwijze ter bereiding van dergelijke verbindingen. | |
| SE428017B (sv) | Forfarande for framstellning av 2,6 - metano - 2h-l- bensoxocinderivat | |
| SE7609769L (sv) | 1,2-bensisoxazolderivat | |
| NL7607483A (nl) | Werkwijze ter bereiding van nitrilderivaten. | |
| NL7604099A (nl) | Werkwijze voor het vervaardigen van een condensa- tor. | |
| SU645558A3 (ru) | Способ получени производных оксима или их солей | |
| SU674671A3 (ru) | Способ получени производных пирролидина | |
| SU674673A3 (ru) | Способ получени производных хиноксалина | |
| SE385177B (sv) | Framkopplad forsterkare | |
| NL7513517A (nl) | Derivaat van 5,7-dihydroxy-tetrahydroisochinoline. | |
| SE423233B (sv) | Analogiforfarande for framstellning av 1,2,3,4-tetrahydroisokinoliner | |
| SU637075A3 (ru) | Способ получени 2,5-дихлор-п-ксилола |